What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease? Ingrid Rivera-Iñiguez; Arturo Panduro; Sonia Roman; Karina González-Aldaco;

Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease Diego García-Compeán; Emanuela Orsi; Tsutomu Nishida; Ramesh Kumar;

Antibiotic consumption, genetic risk and incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study Ziming Zheng; Yumei Huang; Jijuan Zhang; Jinchi Xie; An Pan; Yunfei Liao; Yu Zhang;